University of Maryland Medical Center; Department of Neurology

22 South Greene Street
Baltimore, Maryland 21201

We've found

1 trials

at this facility

Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Baltimore, MD

Use our guide to learn which trials are right for you!